Eight cases of malignant mixed müllerian tumor (carcinosarcoma) of the uterus: Findings in surepath™ cervical cytology

Diagnostic Cytopathology

Volumn 42, Issue 2, 2014, Pages 165-169

  Gupta, Nalini ^a   Dudding, Nicholas ^b   Smith, J H F ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

carcinosarcoma; malignant mixed mesodermal tumor; malignant mixed M llerian tumor; MMMT; SurePath Cervical sample

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CARCINOSARCOMA; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC KIT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT MIXED MULLERIAN TUMOR; MIXED MULLERIAN TUMOR; PAPANICOLAOU TEST; PRIORITY JOURNAL; SAMPLE; UTERINE CERVIX CYTOLOGY; UTERUS CANCER; VAGINA BLEEDING;

CARCINOSARCOMA; MALIGNANT MIXED MESODERMAL TUMOR; MALIGNANT MIXED MÜLLERIAN TUMOR; MMMT; SUREPATH CERVICAL SAMPLE;

AGED; AGED, 80 AND OVER; CARCINOSARCOMA; FEMALE; HUMANS; MIDDLE AGED; MIXED TUMOR, MULLERIAN; UTERINE HEMORRHAGE; UTERINE NEOPLASMS; VAGINAL SMEARS;

EID: 84892802747     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22910     Document Type: Article

References (16)

1. Horn LC, Dallacker M, Bilek K,. Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors. Pathologe 2009; 30: 292-301.
2. Snyder MJ, Robboy SJ, Vollmer RT, Dodd LG,. An abnormal cervicovaginal cytology smear in uterine carcinosarcoma is an adverse prognostic sign: Analysis of 25 cases. Am J Clin Pathol 2004; 122: 434-439.
3. Costa MJ, Tidd C, Willis D,. Cervicovaginal cytology in carcinosarcoma [malignant mixed mullerian (mesodermal) tumor] of the uterus. Diagn Cytopathol 1992; 8: 33-40.
4. Tenti P, Babilonti L, La Fianza A, et al. Cytology of malignant mixed mesodermal tumor of the uterus: Experience of 10 cases. Eur J Gynaecol Oncol 1989; 10: 125-128.
5. Massoni EA, Hajdu SI,. Cytology of primary and metastatic uterine sarcomas. Acta Cytol 1984; 28: 93-100.
6. Casey MB, Caudill JL, Salomão DR,. Cervicovaginal (Papanicolaou) smear findings in patients with malignant mixed müllerian tumors. Diagn Cytopathol 2003; 28: 245-249.
7. Parker JE,. Cytologic findings associated with primary uterine malignancies of mixed cell types (malignant mixed mullerian tumor). Acta Cytol 1964; 8: 316-320.
8. Barbazza R, Infantolino D, Blandamura S, Busato M, Dalla Palma P,. Malignant mixed mullerian tumor of the endometrium. Report of a case with cytological diagnosis. Eur J Gynaecol Oncol 1988; 9: 381-385.
9. Chute DJ, Lim H, Kong CS,. BD focalpoint slide profiler performance with atypical glandular cells on SurePath Papanicolaou smears. Cancer Cytopathol 2010; 118: 68-74.
10. Banik T, Halder D, Gupta N, Dey P,. Malignant mixed Müllerian tumor of the uterus: Diagnosis of a case by fine-needle aspiration cytology and review of literature. Diagn Cytopathol 2012; 40: 653-657.
11. Larson DM, Johnson KK, Reyes CN Jr, et al. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol 1994; 84: 399-403.
12. Richard K, Dziura B, Hornish A,. Cell block preparation as a diagnostic technique complementary to fluid-based monolayer cervicovaginal specimens. Acta Cytol 1999; 43: 69-73.
13. Diaz-Rosario LA, Kabawat SE,. Cell block preparation by inverted filter sedimentation is useful in the differential diagnosis of atypical glandular cells of undetermined significance in ThinPrep specimens. Cancer 2000; 90: 265-272.
14. Risse EK, Holierhoek JP, Meijer-Marres EM, Ouwerkerk-Noordam E, Boon ME,. Increased diagnostic accuracy of atypical glandular cells in cervical liquid-based cytology using cell blocks. Cytopathology 2011; 22: 253-260.
15. Buza N, Tavassoli FA,. Comparative analysis of p16 and p53 expression in uterine malignant mixed müllerian tumors. Int J Gynecol Pathol 2009; 28: 514-521.
16. Franko A, Magliocco AM, Duan Q, Duggan MA,. WT1 immunoprofiling and comparison of malignant Müllerian mixed tumors of the female genital tract. Int J Gynecol Pathol 2010; 29: 452-458.